MYCN and neuroblastoma: This is consistent with the reported role of ELAVL4 in antagonizing downregulation of MYCN expression by miR-17 and recently reported roles in the 3’UTR-dependent enhancement of mRNA translation in neural and neuroblastoma-derived cells (12, 49).